Emily Wagner
Physician Assistant · Brooklyn, IANPI 1982019865
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 255 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,442 and has fallen 62.2% since, to $545 in 2025. Among physician assistant clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 255 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$830
- Pfizer$442
- Amgen$308
- Teva Pharmaceuticals USA, Inc.$288
- Lilly USA, LLC$277
- Boehringer Ingelheim$271
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,13598%
- Education$722%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $830 |
| Pfizer | 29 | $442 |
| Amgen | 22 | $308 |
| Teva Pharmaceuticals USA, Inc. | 16 | $288 |
| Lilly USA, LLC | 20 | $277 |
| Boehringer Ingelheim | 20 | $271 |
| Novo Nordisk | 11 | $190 |
| Biohaven Pharmaceutical Holding Company Ltd. | 14 | $189 |
| AstraZeneca | 11 | $160 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $155 |
| Exact Sciences | 7 | $109 |
| Astellas Pharma US Inc | 3 | $99 |
| Mylan Specialty L.p. | 7 | $96 |
| Novartis | 6 | $91 |
| Nevro Corp. | 1 | $84 |
| Harmony Biosciences LLC | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 4 | $69 |
| Lundbeck LLC | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $51 |
| Bayer | 3 | $50 |
| Kowa Pharmaceuticals America, Inc. | 3 | $45 |
| GSK | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
| Amarin Pharma, Inc. | 2 | $28 |
| Dexcom, Inc. | 1 | $26 |
| Esperion Therapeutics, Inc. | 2 | $23 |
| Seqirus USA Inc | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Boston Scientific | 1 | $15 |
| Viatris Specialty LLC | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $11 |
How this compares
$4,207 in reported general payments places this provider in the 95th percentile of 1,140 physician assistant providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 30 | $18,943 |
| OzempicSemaglutide | 12 | $11,021 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,409 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $4,891 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $3,309 |
| Escitalopram Oxalate | 45 | $401 |
| Atorvastatin Calcium | 54 | $362 |
| Levothyroxine Sodium | 48 | $329 |
| Omeprazole | 36 | $241 |
| Lisinopril | 31 | $227 |
| Metoprolol Succinate | 22 | $178 |
| Losartan Potassium | 19 | $170 |
| Simvastatin | 44 | $141 |
| Amlodipine Besylate | 34 | $136 |
| Benazepril Hcl | 17 | $126 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $442 | $18,94330 claims |
| Novo NordiskOzempic | $190 | $11,02112 claims |
| GSKTrelegy Ellipta | $34 | $8,40913 claims |
| AstraZenecaSymbicort | $160 | $3,30914 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $11 | $32948 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,140 physician assistant providers in Iowa.
Other physician assistant in Brooklyn
- Jayson GesulgaUrbandale$878K
- Laurie ClairJohnston$293K
- Katherine LemAmes$224K
- Laura CunninghamWest Des Moines$128K
- Michon LeddyClive$73K
- Kyle HawkinsIowa City$42K
- Andrew MetzgerIowa City$37K
- Myrl HolidaIowa City$37K
- Kelly MerchieDavenport$15K
- Kathleen DuffyClive$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.